NASDAQ:LQDA
Liquidia Technologies Inc. Stock News
$12.71
-0.0300 (-0.235%)
At Close: May 17, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA
04:42pm, Wednesday, 16'th Dec 2020
New York, New York--(Newsfile Corp. - December 16, 2020) - Pomerantz LLP is investigating claims on behalf of investors of Liquidia Corporation ("Liquidia" or the "Company") (NASDAQ: LQDA). Such inv
Liquidia Corporation Announces Chief Executive Officer Transition
09:28am, Monday, 14'th Dec 2020
RESEARCH TRIANGLE PARK, N.C., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Damian deGoa has been appointed as Chief Executive Officer (CEO) and a director of t
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA
08:13pm, Saturday, 12'th Dec 2020
NEW YORK, Dec. 12, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Liquidia Corporation (“Liquidia” or the “Company”) (NASDAQ: LQDA). Such investor
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA
08:22pm, Monday, 07'th Dec 2020
NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Liquidia Corporation (“Liquidia” or the “Company”) (NASDAQ: LQDA). Such investors ar
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA
08:49pm, Monday, 30'th Nov 2020
NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Liquidia Corporation (“Liquidia” or the “Company”) (NASDAQ: LQDA). Such investor
Liquidia Corporation Appoints Michael Kaseta Chief Financial Officer
07:15am, Monday, 30'th Nov 2020
RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Michael Kaseta has been appointed Chief Financial Officer (CFO), effective immediate
Liquidia (LQDA) PAH Drug Gets FDA's Complete Response Letter
09:14am, Thursday, 26'th Nov 2020
The CRL issued to the NDA for Liquidia's (LQDA) LIQ861 stated that the FDA cannot approve the NDA in its present form
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA
11:10pm, Wednesday, 25'th Nov 2020
NEW YORK, Nov. 25, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Liquidia Corporation ("Liquidia" or the "Company") (NASDAQ: LQDA). Such investors are advised to
CRL does not cite need for additional clinical studies
Liquidia Closes Acquisition of RareGen
04:01pm, Wednesday, 18'th Nov 2020
Merger Reinforc es Company's Commitment to Patients with PAH
Liquidia Announces Results of Special Meeting of Stockholders
07:15am, Monday, 16'th Nov 2020
Stockholders Approve RareGen Acquisition
Liquidia Technologies, Inc. (LQDA) CEO Neal Fowler on Q3 2020 Results - Earnings Call Transcript
12:32pm, Monday, 09'th Nov 2020
Liquidia Technologies, Inc. (LQDA) CEO Neal Fowler on Q3 2020 Results - Earnings Call Transcript
Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate Update
07:15am, Monday, 09'th Nov 2020
- Raised $75 M illion through Underwritten Public Offering - Bolstered and Defended LIQ861 Patent Position - Advanced Efforts in Support of the RareGen, LLC Merger and Integration - Company to Host We
Company Determines Unsolicited Offer does not Constitute Superior Proposal
UPDATE – Liquidia to Report Third Quarter 2020 Financial Results and Provide Corporate Update on November 6, 2020
08:40pm, Friday, 30'th Oct 2020
Company to Host Webcast and Conference Call November 9, 2020 at 8:00a.m. ET Company to Host Webcast and Conference Call November 9, 2020 at 8:00a.m. ET
